Aspen CEO On Currency Pressures: Aspen Pharmacare, Africa's largest generic-drug maker, posted a 3.9 percent gain in full-year profit, as the expansion of its international business outweighed the rising cost of imported materials. CNBC Africa's David Williams spoke with CEO, Steven Saad for more.
BusinessDay TV: Giulietta Talevi and Alishia Sekam discussed the results and currency volatility with Stephen Saad
702’s The Money Show: Bruce Whitfield interviewed Stephen Saad.
Moneyweb: Siki Mgabadeli chatted to Stephen Saad about the year end results and the Group's rapid international growth.
Fine Business Radio: Lindsay Williams analyzed the results with Stephen Saad and discussed the Group’s continued global success
14 September 2015: BusinessDay TV Stock Pick - Liston Meintjes from Sasfin Asset Management takes Giulietta Talevi through his stock pick of the day: ASPEN / R311.00 / Up 1.09%
Aspen’s half year gross revenue surged by 47% to R19 billion. CNBC Africa’s David Williams chatted with Aspen Group Chief Executive Stephen Saad about the results.
CNBC Africa: Aspen - Hot or Not - Guest Rowan Willams from Nitrogen Fund Managers and Byron Lotter from Vestact has selected Aspen as today's stock pick within the pharmaceuticals sector.
BDTV - Alishia Seckam and Stephen Saad discuss the group’s half-year results and the contribution from new acquisitions
Fine Business Radio’s Lindsay Williams spoke to Stephen Saad about Aspen’s remarkable growth and results.
Moneyweb - Hanna Barry and Gus Attridge focused on Aspen’s results, consolidation prospects and its strategy across emerging markets
21 December 2015. CNN Marketplace addressing some of Africa’s health challenges with Stavros Nicolaou.
11 September 2015: BusinessDay TV - The week that was - Stephen Gunnion, Giulietta Talevi and Sasfin's David Shapiro round up the week's biggest business news. View the footage about Aspen from
16 July 2015: CNBC Africa - Aspen’s prospects in Russia
Senior executive at Aspen Pharmacare, Stavros Nicolaou, who is also a member of South Africa's BRICS business council --spoke to CNBC Africa during the recent BRICS summit about the prospects that exist for the pharmaceutical heavyweight to enter the Russian market.
13 March 2015: CNBC Africa - GSK sells half of its stake in Aspen
British drug manufacturer GlaxoSmithKline has sold half of its shareholding in Aspen Pharmacare for ZAR10.5. Joining CNBC Africa to discuss more about the selloff as well as GSK's relationship with Aspen is the latter's deputy group chief executive Gus Attridge.
23 January 2015: Business Day TV Business News - Aspen shares jump on $142 million pharmaceuticals deal with Novartis. Anglo American Platinum warns that full-year headline earnings may fall by as much as 55% And Anglo American is reported to be mulling the sales of coal mines in Australia.